@article{48f4921a5903476e8e919bf70376ee40,
title = "Industrial pharmaceutical drug research has done more for the health of people with MS than academic neurologists: No",
author = "Weinshenker, {Brian G.}",
note = "Funding Information: Dr Weinshenker serves on data safety monitoring boards for Novartis and Biogen Idec; has received payment for consultation from Elan Pharmaceuticals, GlaxoSmithKline Pharmaceuticals and from Asahi Kasei Kuraray Medical Co, Ltd.; serves on the editorial boards of the Canadian Journal of Neurological Sciences, the Turkish Journal of Neurology, and Multiple Sclerosis Journal; has received research support from the Guthy-Jackson Charitable Foundation; and receives license royalties from RSR Ltd for a patent re AQP4-associated antibodies for diagnosis of neuromyelitis optica.",
year = "2012",
month = sep,
doi = "10.1177/1352458512458043",
language = "English (US)",
volume = "18",
pages = "1211--1212",
journal = "Multiple Sclerosis Journal",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "9",
}